Neuren Pharmaceuticals Ltd. (NURPF)
8.80
-3.22
(-26.79%)
USD |
OTCM |
Feb 06, 14:32
Neuren Pharmaceuticals Market Cap : 1.111B for Feb. 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 63.26M |
| Kazia Therapeutics Ltd. | 65.47M |
| Immutep Ltd. | 382.09M |
| Algorae Pharmaceuticals Ltd. | 13.33M |
| Starpharma Holdings Ltd. | 117.10M |
Market Cap Related Metrics
| PS Ratio | 8.003 |
| PEG Ratio | 0.0723 |
| Price to Free Cash Flow | 13.07 |
| Price | 8.80 |
| Earnings Yield | 8.54% |
| PEGY Ratio | 0.0723 |
| Operating PE Ratio | 9.502 |
| Normalized PE Ratio | 11.66 |